Aspergillus serology, from yesterday to today for tomorrow;Sérologie aspergillaire, d'hier à aujourd'hui pour demain

Journal de Mycologie Medicale

Volumn 22, Issue 1, 2012, Pages 72-82

  Persat, F ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Antibodies; Antigens; Aspergillus; Elisa; Immunoelectrophoresis; Serodiagnosis; Serology

Indexed keywords

FUNGUS ANTIBODY; GALACTOMANNAN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ASPERGILLOMA; ASPERGILLUS; ASPERGILLUS SEROLOGY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; FOLLOW UP; FRANCE; FUNGAL DETECTION; HUMAN; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MYCOLOGY; NONHUMAN; REVIEW; SERODIAGNOSIS;

ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; FRANCE; HUMANS; LUNG DISEASES, FUNGAL; PRECIPITIN TESTS; SEROLOGIC TESTS;

ASPERGILLUS;

EID: 84858281897     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2012.01.004     Document Type: Review

References (75)

1. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009, 135:805-826.
2. Agarwal R., Aggarwal A.N., Gupta D., Jindal S.K. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009, 13:936-944.
3. Arruda K., Platts-Mills T.A.E., Fox J.W., Chapman M.D. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J Exp Med 1990, 172:1529-1532.
4. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infec Dis 2002, 34:7-14.
5. Barton R.C., Hobson R.P., Denton M., Peckham D., Kerr Brownlee K., Conway S., et al. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus. Diagn Microbiol Infect Dis 2008, 62:287-291.
6. Baxter C, Jones A, Webb K, Gore R, Denning D. A comparison of the precipitation technique and immunocap FIEA for measurement of IgG antibodies to Aspergillus fumigatus. Conference Proceedings AAA 4th 2010; site internet: http://www.aspergillus.org.uk/secure/conferences/confabstracts/searchconfAAA.php%3Fthis_page=43%26no_of_results=229%26authorsearch=%26authboolean=AND%26searchkeyword=%26keywboolean=AND%26abbrevselect=AAA+4th%26Submit=GO.
7. Biguet J., Tran Van Ky P., Capron A., Fruit J. Analyse immunoélectrophorétique des fractions antigéniques solubles d'Aspergillus fumigatus. Ordre d'apparition des anticorps expérimentaux du lapin ; comparaison de ces derniers avec des anticorps naturels humains. C R Hebd Seances Acad Sci 1962, 254:3768-3770.
8. Biguet J., Tran Van Ky P., Andrieu S., Fruit J. Analyse immunoélectrophorétique d'extraits cellulaires et de milieux de culture d'Aspergillus fumigatus par des immuns sérums expérimentaux et des sérums de malades atteints d'aspergillome bronchopulmonaire. Ann Inst Pasteur 1964, 107:72-97.
9. Binder R.E., Faling L.J., Pugatch R.D., Mahasaen C., Snider G.L. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982, 61:109-124.
10. ® (Beckman) appliquée au sérodiagnostic aspergillaire. J Mycol Med 1994, 4:220-225.
11. Brummund W., Resnick A., Fink J.N., Kurup V.P. Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol 1987, 25:5-9.
12. Casadevall A., Pirofski L.A. Host-pathogen interactions redefining the basic concepts of virulence and pathogenicity. Infect Immun 1999, 67:3703-3713.
13. Cattiaux L., Sendid B., Collot M., Machez E., Poulain D., Mallet J.M. Synthetic biotinylated tetra β (1→5) galactofuranoside for in vitro aspergillosis diagnosis. Bioorg Med Chem 2011, 19:547-555.
14. Chan C.M., Woo P.C.Y., Leung A.S.P., Lau S.K.P., Che X.Y., Cao L., et al. Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol 2002, 40:2041-2045.
15. Clancy1C, Wingard J, Nguyen M. Elevated serum IgG responses against Aspergillus fumigatus proteins prior to hematopoietic stem cell transplant (HSCT) identify patients at risk for invasive aspergillosis (IA). Conference Proceedings AAA4th 2010; accès internet: http://www.aspergillus.org.uk/secure/conferences/confabstracts/searchconfAAA.php%3Fthis_page=43%26no_of_results=229%26authorsearch=%26authboolean=AND%26searchkeyword=%26keywboolean=AND%26abbrevselect=AAA+4th%26Submit=GO.searchconfAAA.php%3Fthis_page=43%26no_of_results=229%26authorsearch=%26authboolean=AND%26searchkeyword=%26keywboolean=AND%26abbrevselect=AAA+4th%26Submit=GO.
16. Coleman R.M., Kaufman L. Use of the immunodiffusion test in the serodiagnosis of aspergillosis. App Microbiol 1972, 23:301-308.
17. Cornillet A., Camus S., Nimubona S., Gandemer V., Tattevin P., Belleguic C., et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clinical Infectious Diseases 2006, 43:577-584.
18. Delhaes L., Frealle E., Pinel C. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges. Med Mycol 2010, 48:S77-S87.
19. Denning D.W., Riniotis K., Dobrashian R., Sambatak H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003, 37:S265-S280.
20. Denning DW. The extraordinary spectrum of diseases caused by Aspergillus. International Union of Microbiological Societies 2011; site internet: http://www.aspergillus.org.uk/indexhome.htm%3Feducation/slides.htm~main.
21. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive. Clin Infect Dis 2008, 46:1813-1821.
22. Drouhet E., Camey L., Segretain G. Valeur de l'immunoprécipitation et de l'immunofluorescence indirecte dans les aspergilloses broncho-pulmonaires. Ann Inst Pasteur 1972, 123:379-395.
23. Drouhet E., Tabet-Derraz O., Sanchez-Sousa A., Viviani M.A. Application de l'électrosynérèse et de l'immunoélectrophorèse bidimensionnelle au diagnostic des aspergilloses et à la standardisation des antigènes aspergillaires. Bull Soc Fr Myc Med 1973, 2:7-10.
24. Framatico P.M., Buckley H.R. Identification and characterization of an immunodominant 58-kilodalton antigen of Aspergillus fumigatus recognized by sera of patients with invasive aspergillosis. Infect Immun 1991, 59:309-315.
25. Fricker-Hidalgo H., Coltey B., Llerena C., Renversez J.C., Grillot R., Pin I. Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol 2010, 17:1330-1336.
26. Gangneux J.P., Camus C., Philippe B. Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients. Rev Mal Resp 2010, 27:34-46.
27. Grabar P., Williams C.A. Méthodes permettant l'étude conjuguée des proprieties électrophorétiques et immunochimiques d'un mélange de proteins. Application au sérum sanguin. Biochim Biophys Acta 1953, 10:193-194.
28. Grillot R., Lebeau B., Pinel C., Fricker H., Ambroise-Thomas P. Diagnostic biologique des mycoses systémiques en onco-hématologie. J Mycol Med 1991, 1:4-10.
29. Guitard J., Sendid B., Thorez S., Gits M., Hennequin C. Evaluation of a recombinant antigen-based EIA for the diagnosis of non-invasive aspergillosis. J Clin Microbiol 2011, 10.1128/JCM.01257 11.
30. Harvey C., Longbottom J.L. Characterization of a second major antigen Ag 13 (antigenC) of Aspergillus fumigatus and investigation of its immunological reactivity. Clin Exp Immunol 1987, 70:247-254.
31. He H., Ding L., Li F., Zhan Q. Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study. Critical Care 2011, 15:2-12.
32. Hearn V.M., Wilson E.V., Proctor A.G., MacKenzie D.W.R. Preparation of Aspergillus fumigatus antigens and their analysis by two-dimensionnal immunoelectrophoresis. J Med Microbiol 1980, 3:451-458.
33. Hoppe W.W., Walsh T.J., Denning D.W. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005, 5:609-622.
34. Kappe R., Rimek D. Antibody detection in patients with invasive aspergillosis. Mycoses 2004, 47:55-59.
35. Kaufmann H.F., Beaumont F., Meurs H., Van der Heide S., De Vries K. Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). J Allergy Clin Immunol 1983, 72:255-261.
36. Kitasato Y., Tao Y., Hoshino H., Tachibana K., Inoshima N., Yoshida M. Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 2009, 14:701-708.
37. Krakova P., Halweg H., Podsiado B. Mycological and serological studies in the diagnosis of various forms of pulmonary aspergillosis. Scand J Respir Dis 1978, 2:213-216.
38. Kurup P.V., Kumar A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991, 4:439-456.
39. Kurup V.P., Knutsen A.P., Moss R.B., Bansal N.K. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol Allergy 2006, 4:11-17.
40. Latgé J.P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999, 12:310-350.
41. Latgé J.P. Tasting the fungal cell wall. Cell Microbiol 2010, 12:863-872.
42. Latgé J.P., Kobayashi H., Debeaupuis J.P., Diaquin M., Sarfati J., Wieruszeski J.M., et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infec Immun 1994, 62:5424-5433.
43. Latgé J.P., Moutaouakil M., Debeaupuis J.P., Bouchara J.P., Haynes K., Prevost M.C. The 18-kilodalton antigen secreted by Aspergillus fumigatus. Infect Immun 1991, 59:2586-2594.
44. Latzin P., Hartl D., Regamey N., Frey U., Schoeni M.H., Casaulta C. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2008, 31:36-42.
45. Leeflang M.M., Debets-Ossenkopp Y.J., Visser C.E., Scholten R.J., Hooft L., Bijlmer H.A., et al. Galactomannan detection for invasive aspergillosis in immunocompromized patient. Cochrane Database Syst Rev 2008, 4:CD007394.
46. Longbottom J.L., Pepys J., Temple Clive F. Diagnostic precipitin test in Aspergillus pulmonary mycetoma. Lancet 1964, 1:588-589.
47. Longbottom J.L., Pepys J. Pulmonary aspergillosis: diagnostic and immunological significance of antigens and C-substance in Aspergillus fumigatus. J Path Bact 1964, 88:141-152.
48. Mikulska M, Calandra T, Sanguinetti M, Daniel Poulain D, Viscoli C. Non-invasive diagnostic procedures for yeast infections. 3rd European Conference on infections in leukemia 2009; 25-26 September, Juan les Pins, France. Accès internet: http://www.eortc.be/home/IDG/ECIL/ECIL%203%20Non%20culture-based%20diagnostic%20procedures%20for%20Aspergillus.pdf.
49. Nam H.S., Jeon K., Um S.W., Suh G.Y., Chung M.P., Kim H., et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010, 14:479-482.
50. Ouchterlony Ö. Antigen-antibody reactions in gels. Acta Path Microbiol Scand 1949, 26:507-515.
51. Patterson R., Wang J.L.F., Roberts M., Zeiss C.R. Comparison of radioimmunoassay techniques in the detection of IgE and IgG antibody activity against Aspergillus fumigatus antigens. J Immunol 1978, 120:66-71.
52. Persat F., Ranque S., Derouin F., Michel-Nguyen A., Picot S., Sulahian A. Contribution of the (133)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008, 46:1009-1013.
53. Pfeiffer C.D., Fine J.P., Safdan N. Diagnosis of invasive aspergillosis using a Galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427.
54. Piechura J.E., Huang C.J., Cohen S.H., Kidd J.M., Kurup V.P. Antigens of Aspergillus fumigatus. II Electrophoretic and clinical studies. Immunol 1983, 49:657-665.
55. Pinel C., Fricker-Hidalgo H., Lebeau B., Garban F., Hamidfar R., Ambreoise-Thomas P., et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003, 41:2184-2186.
56. Pinon J.M., Charpentier O., Level M.C., Remy G., Sulahian A., Dropsy G. Etude critique des réactions immuno-enzymatiques couplées aux tests de précipitation sur membranes d'acétate de cellulose. Bull Soc Pathol Exot 1978, 77:189-195.
57. Sarfati J., Monod M., Recco P., Sulahian A., Pinel C., Candolfi E., et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 2006, 55:279-291.
58. Schoenheyder H., Andersen P., Stenderup A. Serum antibodies to Aspergillus fumigatus in patients with pulmonary aspergillosis detected by immunofluorescence. Acta Path Microbiol Immunol Scand 1982, 90:273-279.
59. Schoenheyder H. Pathogenetic and serological aspects of pulmonary aspergillosis. Scand J Infect Dis Suppl 1987, 51:1-62.
60. Schoenheyder H., Jensen T., Laessoe I.H., Hoiby N., Koch C. Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 1988, 7:40-44.
61. Sepulveda R., Longbottom J.L., Pepys J. Enzyme linked imunosorbent assay (ELISA) for IgG and IgE antibodies to protein and polysaccharide antigens of Aspergillus fumigatus. Clin Allergy 1979, 9:359-371.
62. Singh B., Oellerich M., Kumar R., Mumar M., Rhadoria D., Reichard U., et al. Immuno reactive molecules identified from the secreted proteome of Aspergillus fumigatus. J Prot Res 2010, 9:5517-5529.
63. Skov M., Presslet T., Jensen H.E., Hoiby N., Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999, 54:44-50.
64. Smith N.L., Denning D.W. Underlying conditions in chronic pulmonary aspergillosis, including simple aspergilloma. Eur Respir J 2011, 37:865-872.
65. Stevens D.A., Moss R.B., Kurup V.P., Knutsen A.P., Greenberger P., Juds M.A., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: cystic fibrosis foundation consensus conference. Clin Infect Dis 2003, 37:S225-S264.
66. Tönder O., Rödsaether M. Indirect haemagglutination for demonstration of antibodies to Aspergillus fumigatus. Act Path Microbiol Scand 1974, 82:871-878.
67. Thornton C. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vacc Immunol 2008, 15:1095-1105.
68. Tran Van Ky P., Biguet J., Fruit J. Localisation et fréquence des arcs des immunoélectrophorégrammes produits par le sérum des malades atteints de mycétomes aspergillaires appliqués contre l'antigène Aspergillus fumigatus. Rev Immunol 1966, 30:13-20.
69. Tran Van Ky P., Vaucelle T. étude d'une fraction antigénique d'Aspergillus fumigatus support d'une activité catalasique. Conséquence sur le diagnostic immunologique de l'aspergillose. Rev Immunol 1968, 1-2:37-52.
70. Van Hoeyveld E., Dupont L., Bossuyt X. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique?. Clin Chem 2006, 52:1785-1793.
71. Verweij P.E. Galactomannan and anti-Aspergillus antibody detection for the diagnosis of invasive aspergillosis. Aspergillus fumigatus and aspergillosis 2008, 363-372. [chapitre 28]. J.P. Latgé, W.J. Steinbach (Eds.).
72. Weig M., Frosch M., Tintelnot K., Haas A., Gross U., Linsmeier B., et al. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol 2001, 39:1721-1730.
73. Yarzabal L.A., Da Luz S., Josey M., Torres J.M., Vigna, Olga Muras I. Pruebas de inmunoprecipitacion en el diagnostico de la aspergilosis. Rev Inst Med Trop Sao Paulo 1973, 15:1-9.
74. Yoneda A., Kurokawa T. A sensitive sandwich ELISA to measure (1→3)-β-D-glucan levels in blood. J Immunol Methods 2011, 365:158-165.
75. Zait H., Hamrioui B. Aspergillome pulmonaire: à propos de 39 cas. J Mycol Med 2011, 21:138-141.